EPTIS – Clinical PT- Immunoproteins I (EPTIS-ID 445441)

Clinical PT- Immunoproteins I

[EP Clínico- Imunoproteínas I]

EPTIS factsheet 445441 | Last revision 2020-09-18 | URL: https://www.eptis.bam.de/pts445441 https://www.eptis.bam.de/pts445441

PT provider

PT provider

ControlLab Controle de Qualidade para Laboratórios Ltda

Based in

Brazil

Language(s)

Portuguese/ English / Spanish

Remarks

Keywords

Product groups

Health care / medical devices
Human test material
Laboratory / scientific equipment
Process control systems

Testing fields

Biology
Medical analysis

Technical details

Test item	Tested property	Testing method
Lyophilised human serum	AH-50	Routine methods of participants
	Alpha-1-acid glycoprotein	Routine methods of participants
	Amyloid A	Routine methods of participants
	Complement C1q	Routine methods of participants
	Complement C2	Routine methods of participants
	Complement C3	Routine methods of participants
	Complement C3 proactivator	Routine methods of participants
	Complement C4	Routine methods of participants
	Complement C5	Routine methods of participants
	Complement C8	Routine methods of participants
	Complement C9	Routine methods of participants
	IgD (immunoglobulin D)	Routine methods of participants
	IgG1 (immunoglobulin G1)	Routine methods of participants
	IgG2 (immunoglobulin G2)	Routine methods of participants
	IgG3 (immunoglobulin G3)	Routine methods of participants
	IgG4 (immunoglobulin G4)	Routine methods of participants
	IgA (immunoglobulin A)	Routine methods of participants
	IgE (immunoglobulin E)	Routine methods of participants
	IgG (immunoglobulim G)	Routine methods of participants
	IgM (immunoglobulin M)	Routine methods of participants
	Inhibitor of C1 sterase	Routine methods of participants

Aims of the PT scheme

Target group of participants

No restrictions.

Linked to specific legislation / standards

ABNT NBR ISO/IEC 17043

Additional, subsidiary aims

Number of participants

Accredited or otherwise reviewed by a 3^rd party

Accredited by Coordenação Geral de Acreditação do Inmetro - Cgcre on the basis of ABNT NBR ISO/IEC 17043:2011, anexo B2, B.2.1.e) for part of the parameters

Operation is commissioned / requested by

Fees and frequency

Participation fee

Variable costs. For this information, please contact ControlLab.

Regularly operated

Yes (4 rounds per year)

Year of first operation

2006

Contact details of the PT provider

Provider

Contact person

ControlLab Controle de Qualidade para Laboratórios Ltda
Rua Ana Neri 416 Benfica
20911-442 Rio de Janeiro
Brazil

Phone: +55-21-3891 9900
Fax: +55-21-3891 9901
Web: http://www.controllab.com.br

Vinicius Biasoli
Phone: +55-21-3891 9900
Fax: +55-21-3891 9901
Email: eptis@controllab.com

If you find any mistakes please contact the responsible EPTIS coordinator in Brazil, Mr José Ricardo Bardellini da Silva.

Clinical PT- Immunoproteins I [EP Clínico- Imunoproteínas I] EPTIS factsheet 445441 | Last revision 2020-09-18 | URL: https://www.eptis.bam.de/pts445441 https://www.eptis.bam.de/pts445441

Clinical PT- Immunoproteins I

[EP Clínico- Imunoproteínas I]

EPTIS factsheet 445441 | Last revision 2020-09-18 | URL: https://www.eptis.bam.de/pts445441 https://www.eptis.bam.de/pts445441